Authors:
VIENS P
GENRE D
PROTIERE C
GRAVIS G
BERTUCCI F
COWEN D
CAMERLO J
CHABANNON C
NOVAKOVITCH G
CONTE M
FINAUD M
MOATTI JP
MARANINCHI D
Citation: P. Viens et al., BENEFITS OF GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER STEM-CELL TRANSFUSION IN INTENSIVE SEQUENTIAL CHEMOTHERAPY FOR BREAST-CANCER, European cytokine network, 9(1), 1998, pp. 93-98
Authors:
ODDOU S
VEY N
VIENS P
BARDOU VJ
FAUCHER C
STOPPA AM
CHABANNON C
CAMERLO J
BOUABDALLAH R
GASTAUT JA
MARANINCHI D
BLAISE D
Citation: S. Oddou et al., 2ND NEOPLASMS FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR MALIGNANT-LYMPHOMAS - A REPORT OF 6 CASES IN A COHORT OF 171 PATIENTS FROM A SINGLE INSTITUTION, Leukemia & lymphoma, 31(1-2), 1998, pp. 187-194
Authors:
DAZIANO JP
HUMEAU L
HENRY M
MANNONI P
CHANON M
CHABANNON C
JULLIARD M
Citation: Jp. Daziano et al., PREFERENTIAL PHOTOINACTIVATION OF LEUKEMIA-CELLS BY ALUMINUM PHTHALOCYANINE, Journal of photochemistry and photobiology.B, Biology, 43(2), 1998, pp. 128-135
Authors:
AUSTRUY E
BAGNIS C
CARBUCCIA N
MAROC C
BIRG F
DUBREUIL P
MANNONI P
CHABANNON C
Citation: E. Austruy et al., A DEFECTIVE RETROVIRAL VECTOR ENCODING HUMAN INTERFERON-ALPHA-2 CAN TRANSDUCE HUMAN LEUKEMIC-CELL LINES, Cancer gene therapy, 5(4), 1998, pp. 247-256
Citation: L. Humeau et al., HUMAN CD34(+) CD38(-) FETAL LIVER-CELLS A RE ABLE TO REPOPULATE MYELOID, B-LYMPHOID AND T-LYMPHOID LINEAGES IN SCID-HU MICE/, MS. Medecine sciences, 14(3), 1998, pp. 356-357
Citation: C. Chabannon, FROM SCIENCE TO MEDICINE, AN UNCERTAIN ST EP - LESSONS FROM CD34(+) CELL SELECTION DEVICES, MS. Medecine sciences, 14(2), 1998, pp. 183-187
Authors:
CHABANNON C
AURRAN T
VIRET F
FAUCHER C
STOPPA AM
LADAIQUE P
VEY N
BOUABDALLAH R
NOVAKOVITCH G
GASTAUT JA
MARANINCHI D
BLAISE D
Citation: C. Chabannon et al., OUTCOME OF PATIENTS AT HIGH-RISK OF DEVELOPING GVHD, AFTER ALLOGENEICTRANSPLANTATION OF SELECTED CD34-CELLS( BLOOD), Experimental hematology, 26(8), 1998, pp. 364-364
Authors:
IMBERT AM
BAGNIS C
GALINDO R
CHABANNON C
MANNONI P
Citation: Am. Imbert et al., A NEUTRALIZING ANTI-TGF-BETA-1 ANTIBODY PROMOTES PROLIFERATION OF CD34(-1(+) PERIPHERAL-BLOOD PROGENITORS AND INCREASES THE NUMBER OF TRANSDUCED PROGENITORS()THY), Experimental hematology, 26(5), 1998, pp. 374-381
Authors:
FAUCHER C
FORTANIER C
LECORROLLER AG
CHABANNON C
MAQUARTMOULIN G
NOVAKOVITCH G
CHABBERT I
SCHULLER MP
MARANINCHI D
MOATTI JP
BLAISE D
Citation: C. Faucher et al., CLINICAL ECONOMIC AND QUALITY-OF-LIFE ASSESSMENT OF LENOGRASTIM PRIMING AND PERIPHERAL-BLOOD PROGENITOR CELLS (PBSC) HARVESTING FOR 31 HEALTHY DONORS, Bone marrow transplantation, 21, 1998, pp. 1-1
Authors:
FAUCHER C
FORTANIER C
VIENS P
LECORROLLER AG
CHABANNON C
CAMERLO J
NOVAKOVITCH G
GASTAUT JA
MARANINCHI D
MOATTI JP
BLAISE D
Citation: C. Faucher et al., CLINICAL AND ECONOMIC COMPARISON OF LENOGRASTIM-PRIMED BLOOD-CELLS (BC) AND BONE-MARROW (BM) ALLOGENEIC TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 92-98
Authors:
VIRET F
CHABANNON C
VEY N
STOPPA AM
FAUCHER C
NOVAKOVITCH G
OZIELTAIEB S
GASTAUT JA
MARANINCHI D
BLAISE D
Citation: F. Viret et al., EFFECTIVE T-CELL DEPLETION OF ALLOGENEIC BLOOD AND MARROW GRAFTS, USING A CD34+ CELL SELECTION DEVICE, Bone marrow transplantation, 21, 1998, pp. 102-102
Authors:
CHARBONNIER A
SAINTY D
ARNOULET C
FAUCHER C
VIRET F
VEY N
STOPPA AM
CHABANNON C
MARANINCHI D
BLAISE D
Citation: A. Charbonnier et al., IMMUNE RECOVERY AFTER ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION - A COMPARATIVE-STUDY OF 78 PATIENTS, Bone marrow transplantation, 21, 1998, pp. 103-103
Authors:
BLAISE D
JOURDAN E
FEGUEUX N
MICHALLET M
REIFFERS J
JOUET JP
MICHEL G
FAUCHER C
FORTANIER C
SCHULLER MP
BADRI N
CHABANNON C
MARANINCHI D
Citation: D. Blaise et al., IMPACT OF ALLOGENEIC PBSC TRANSPLANTATION IN A POPULATION OF STANDARDRISK PATIENT, Bone marrow transplantation, 21, 1998, pp. 103-103
Authors:
FAUCHER C
FORTANIER C
LECORROLLER AG
CHABANNON C
MAQUARTMOULIN G
NOVAKOVITCH G
CHABBERT I
SCHULLER MP
MARANINCHI D
MOATTI JP
BLAISE D
Citation: C. Faucher et al., CLINICAL ECONOMIC AND QUALITY-OF-LIFE ASSESSMENT OF LENOGRASTIM PRIMING AND PERIPHERAL-BLOOD PROGENITOR CELLS (PBSC) HARVESTING FOR 31 HEALTHY DONORS, Bone marrow transplantation, 21, 1998, pp. 146-146
Authors:
BLAISE D
JOURDAN E
FEGUEUX N
MICHALLET M
REIFFERS J
JOUET JP
MICHEL G
FAUCHER C
FORTANIER C
SCHULLER MP
BADRI N
CHABANNON C
MARANINCHI D
Citation: D. Blaise et al., IMPACT OF ALLOGENEIC PBSC TRANSPLANTATION IN A POPULATION OF STANDARDRISK PATIENT, Bone marrow transplantation, 21, 1998, pp. 147-147
Authors:
STOPPE AM
VEY N
VIRET F
FAUCHET C
CHABANNON C
CAMERLO J
CAPPIELLO M
BLAISE D
MARANINCHI D
Citation: Am. Stoppe et al., EARLY AND PROLONGED (D1-86) ADMINISTRATION OF LOW-DOSE INTERLEUKIN-2 AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES, Bone marrow transplantation, 21, 1998, pp. 363-363
Authors:
AURRANSCHLEINITZ T
HUMEAU L
BARDIN F
IMBERT AM
CHARBORD P
CHABANNON C
Citation: T. Aurranschleinitz et al., BIOLOGICAL EFFECTS OF FLT3-L ON PERIPHERAL-BLOOD PROGENITORS OBTAINEDFROM CANCER-PATIENTS OR HEALTHY DONORS MOBILIZED WITH CHEMOTHERAPY ORRHG-CSF, British Journal of Haematology, 102(1), 1998, pp. 22-22
Authors:
OLIVERO S
LADAIQUE P
ALARIO T
HACCOUN M
NOVAKOVITCH G
VIENS P
BLAISE D
CHABANNON C
Citation: S. Olivero et al., CD34-SAMPLES OR APHERESIS USING DIAGNOSTIC KITS OR AN INSTITUTIONAL PROTOCOL( CELL COUNTS IN BLOOD), British Journal of Haematology, 102(1), 1998, pp. 75-75
Authors:
CHABANNON C
AURRANSCHLEINITZ T
VIRET F
FAUCHER C
STOPPA AM
LADAIQUE R
VEY N
BOUABDALLAH R
NOVAKOVITCH G
GASTAUT JA
MARANINCHI D
BLAISE D
Citation: C. Chabannon et al., OUTCOME OF PATIENTS AT HIGH-RISK OF DEVELOPING GVHD, AFTER ALLOGENEICTRANSPLANTATION OF SELECTED CD34-CELLS( BLOOD), British Journal of Haematology, 102(1), 1998, pp. 319-319
Authors:
CHABANNON C
CORNETTA K
LOTZ JP
ROSENFELD C
SHLOMCHIK M
YANOVITCH S
MAROLLEAU JP
SLEDGE G
NOVAKOVITCH G
SROUR EF
BURTNESS B
CAMERLO J
GRAVIS G
LEEFISCHER J
FAUCHER C
CHABBERT I
KRAUSE D
MARANINCHI D
MILLS B
KUNKEL L
OLDHAM F
BLAISE D
VIENS P
Citation: C. Chabannon et al., HIGH-DOSE CHEMOTHERAPY FOLLOWED BY REINFUSION OF SELECTED CD34(-BLOODCELLS IN PATIENTS WITH POOR-PROGNOSIS BREAST-CANCER - A RANDOMIZED MULTICENTER STUDY() PERIPHERAL), British Journal of Cancer, 78(7), 1998, pp. 913-921
Citation: C. Chabannon et al., WILL CD34+ STANDARDIZATION SOLVE ALL PROBLEMS RELATED TO CELL THERAPY, Journal of hematotherapy, 6(5), 1997, pp. 439-440
Authors:
LECORROLLER AG
MOATTI JP
CHABANNON C
FAUCHER C
BLAISE D
FORTANIER D
LADAIQUE P
BLACHE BL
NOVAKOVITCH G
MARANINCHI D
Citation: Ag. Lecorroller et al., OPTIMIZATION OF PERIPHERAL-BLOOD STEM-CELL COLLECTION (PBSC) BY LEUKAPHERESIS - A CASE OF INTERACTION BETWEEN ECONOMIC AND CLINICAL-ASSESSMENT OF AN INNOVATION, European journal of cancer, 33, 1997, pp. 18-18
Authors:
BAGNIS C
HUMEAU L
IMBERT AM
CHABANNON C
NAMIKAWA R
BLAISE D
MANNONI P
Citation: C. Bagnis et al., GENE MARKING OF HUMAN STEM-CELLS DERIVED FROM PERIPHERAL-BLOOD AND FETAL LIVER - FROM THE PRECLINICAL TESTS TO THE CLINICAL-TRIAL, Cancer gene therapy, 4(6), 1997, pp. 82-82